Literature DB >> 23137279

Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21483 women.

J S Danik1, J E Buring, D I Chasman, R Y L Zee, P M Ridker, R J Glynn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23137279      PMCID： PMC3557784          DOI： 10.1111/jth.12056

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  16 in total

1.  Lipoprotein(a) concentration is not associated with venous thromboembolism in a case control study.

Authors:  G Lippi; A Bassi; G Brocco; F Manzato; M Marini; G Guidi
Journal:  Haematologica       Date:  1999-08       Impact factor: 9.941

2.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.

Authors:  J W McLean; J E Tomlinson; W J Kuang; D L Eaton; E Y Chen; G M Fless; A M Scanu; R M Lawn
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

3.  Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.

Authors:  U Nowak-Göttl; R Junker; M Hartmeier; H G Koch; N Münchow; G Assmann; A von Eckardstein
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

4.  Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.

Authors:  Jacqueline Suk Danik; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

5.  Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.

Authors:  M von Depka; U Nowak-Göttl; R Eisert; C Dieterich; M Barthels; I Scharrer; A Ganser; S Ehrenforth
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

6.  Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis.

Authors:  Pia R Kamstrup; Anne Tybjærg-Hansen; Børge G Nordestgaard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-19       Impact factor: 8.311

7.  Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

Authors:  Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Joseph F Polak; Aaron R Folsom
Journal:  Arch Intern Med       Date:  2002-05-27

8.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

9.  Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism.

Authors:  Rossella Marcucci; Agatina Alessandrello Liotta; Anna Paola Cellai; Angela Rogolino; Anna Maria Gori; Betti Giusti; Daniela Poli; Sandra Fedi; Rosanna Abbate; Domenico Prisco
Journal:  Am J Med       Date:  2003-12-01       Impact factor: 4.965

10.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

Authors:  E Boerwinkle; C C Leffert; J Lin; C Lackner; G Chiesa; H H Hobbs
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808
View more
  12 in total

Review 1.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

Review 2.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

Review 3.  New and emerging biomarkers in cardiovascular disease.

Authors:  Leah E Cahill; Monica L Bertoia; Sarah A Aroner; Kenneth J Mukamal; Majken K Jensen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

Review 4.  Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall.

Authors:  Sabina Ugovšek; Miran Šebeštjen
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

Review 5.  Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2015-12-08       Impact factor: 5.922

6.  Association of vWA and TPOX polymorphisms with venous thrombosis in Mexican mestizos.

Authors:  Marco Antonio Meraz-Ríos; Abraham Majluf-Cruz; Carla Santana; Gino Noris; Rafael Camacho-Mejorado; Leonor C Acosta-Saavedra; Emma S Calderón-Aranda; Jesús Hernández-Juárez; Jonathan J Magaña; Rocío Gómez
Journal:  Biomed Res Int       Date:  2014-08-31       Impact factor: 3.411

7.  Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.

Authors:  Elena Sticchi; Alberto Magi; Pia R Kamstrup; Rossella Marcucci; Domenico Prisco; Ida Martinelli; Pier Mannuccio Mannucci; Rosanna Abbate; Betti Giusti
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

8.  Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.

Authors:  Lishan Sun; Ming Zong; Cuncun Chen; Lihong Xie; Fei Wu; Ming Yu; Lieying Fan
Journal:  Lipids Health Dis       Date:  2018-05-10       Impact factor: 3.876

9.  Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.

Authors:  Gregory G Schwartz; Philippe Gabriel Steg; Michael Szarek; Vera A Bittner; Rafael Diaz; Shaun G Goodman; Yong-Un Kim; J Wouter Jukema; Robert Pordy; Matthew T Roe; Harvey D White; Deepak L Bhatt
Journal:  Circulation       Date:  2020-03-29       Impact factor: 29.690

10.  Serum Lipoprotein (a) on Postoperative Day 3: A Strong Predictor of Portal and/or Splenic Vein Thrombosis in Cirrhotic Patients With Splenectomy.

Authors:  Zhiyong Shi; Mingxia Zhang; Xiushan Dong; Jun Xu
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.